FemTech

Following the recent recommendation from National Institute for Health and Care Excellence (NICE), Yorkshire-based healthcare provider, LivingCare Group, has strengthened its commitment to women’s health with the l...

Pathos AI has signed a collaboration and co-exclusive licensing agreement with AstraZeneca to advance the investigational ERα PROTAC AZD4241 into early clinical development, using its AI-powered Foundry platform to ...

Pfizer has announced the US Food and Drug Administration (FDA) approved IBRANCE (palbociclib) in combination with trastuzumab, with or without pertuzumab, and endocrine therapy for the maintenance treatment of adult ...

PacBio, developer of the world’s most advanced sequencing technologies, has announced the publication of a preprint, describing the first major study from the HiFi Solves Sub-fertility Consortium in Asia Pacific. The s...

On World Breast Cancer Day 2025, Phesi released new data revealing that breast cancer clinical trial expertise is disproportionately concentrated in just two countries – the US and China – while lower-income countries con...

Language barriers are putting both patients and healthcare professionals at risk, with two-thirds (65%) of healthcare workers in female care admitting concerns about safeguarding, according to new research from...